Why Inovio Pharmaceuticals Stock Is Soaring Today
Inovio Pharmaceuticals (NASDAQ: INO), a pre-revenue synthetic vaccine developer, continued its volatile week today. The biotech's shares were up 11% on nearly five times the average daily volume as of 10:37 a.m. EST on Thursday.
Inovio's shares are popping in response to a collaboration agreement with Beijing Advaccine Biotechnology to advance the development of INO-4800 in China. INO-4800 is the biotech's experimental vaccine designed to combat the strain of coronavirus, 2019-nCoV, currently ravaging parts of China. It has since spread to over 20 countries across the globe.
Image source: Getty Images.
Source Fool.com
